|
See related Manoron tab information |
|
|
|
Manufacturer |
March Pharma |
|
Distributor |
March Pharma |
|
Contents |
Cinnarizine HCl |
|
Indications |
Vertiginous syndromes or dizziness, cerebral & peripheral circulatory disorders, migraine, equilibrium disorders, vertigo, motion sickness, vestibular disorders. |
|
Dosage |
1-2 tab tid. |
|
Administration |
Should be taken with food |
|
Contraindications |
Acute asthma attacks. |
|
Special Precautions |
May impair ability to drive or operate machinery. |
|
Adverse Drug Reactions |
Drowsiness, dizziness, GI disturbances.
View ADR Monitoring Form |
|
Drug Interactions |
May enhance sedative effect of CNS depressants.
View more drug interactions with Manoron |
|
Pregnancy Category (US FDA) |
Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus. |
|
Presentation/Packing |
|
Form |
Packing |
Photo |
|
Manoron tablet |
|
Manoron 25 mg x 1,000's |
 |
|
|
|
Manufacturer: |
March Pharma |
|
Distributor: |
March Pharma
|
|
|
|
